CoChat

Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease

Daniels, Anthony B., Chang, Emmanuel Y., Chew, Emily Y., Gombos, Dan S., Gorin, Michael B., Shields, Carol L., Wiley, Henry E. · 2024 · Ophthalmology
Cited by 26

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ophtha.2023.12.014

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 53

  1. Lonser, 2003, von Hippel-Lindau disease, Lancet, 361, 2059, 10.1016/S0140-6736(03)13643-4 · DOI · Paper page
  2. Schmid, 2014, Management of von Hippel-Lindau disease: an interdisciplinary review, Oncol Res Treat, 37, 761, 10.1159/000369362 · DOI
  3. Latif, 1993, Identification of the von Hippel-Lindau disease tumor suppressor gene, Science, 260, 1317, 10.1126/science.8493574 · DOI · Paper page
  4. Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459 · DOI · Paper page
  5. Gossage, 2015, VHL, the story of a tumour suppressor gene, Nat Rev Cancer, 15, 55, 10.1038/nrc3844 · DOI · Paper page
  6. Arreola, 2018, Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch, JCI Insight, 3, e92193, 10.1172/jci.insight.92193 · DOI
  7. Wiley, 2019, Management of retinal hemangioblastoma in von Hippel-Lindau disease, Retina, 39, 2254, 10.1097/IAE.0000000000002572 · DOI
  8. Wong, 2008, Retinal vascular proliferation as an ocular manifestation of von Hippel-Lindau disease, Arch Ophthalmol, 126, 637, 10.1001/archopht.126.5.637 · DOI
  9. Meyerle, 2008, Clinical course of retrobulbar hemangioblastomas in von Hippel-Lindau disease, Ophthalmology, 115, 1382, 10.1016/j.ophtha.2008.01.027 · doi:10.1016/j.ophtha.2008.01.027
  10. Stolle, 1998, Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene, Hum Mutat, 12, 417, 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K · DOI · Paper page
  11. Hes, 2001, Clinical management of von Hippel-Lindau (VHL) disease, Neth J Med, 59, 225, 10.1016/S0300-2977(01)00165-6 · doi:10.1016/s0300-2977(01)00165-6
  12. Binderup, 2013, von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition, Dan Med J, 60, B4763:1
  13. Kruizinga, 2014, Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations, Endocr Relat Cancer, 21, 63, 10.1530/ERC-13-0308 · DOI
  14. Rednam, 2017, von Hippel-Lindau and hereditary pheochromocytoma/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood, Clin Cancer Res, 23, e68, 10.1158/1078-0432.CCR-17-0547 · DOI · Paper page
  15. Grubb, 2005, Management of von Hippel-Lindau-associated kidney cancer, Nat Clin Pract Urol, 2, 248, 10.1038/ncpuro0179 · DOI
  16. Stukalin, 2016, Contemporary treatment of metastatic renal cell carcinoma, Oncol Rev, 10, 295
  17. Binderup, 2017, Survival and causes of death in patients with von Hippel-Lindau disease, J Med Genet, 54, 11, 10.1136/jmedgenet-2016-104058 · DOI · Paper page
  18. Daniels, 2023, Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance, Cancer, 129, 2927, 10.1002/cncr.34896 · DOI · Paper page
  19. Shekelle, 1999, Clinical guidelines: developing guidelines, BMJ, 318, 593, 10.1136/bmj.318.7183.593 · DOI · Paper page
  20. Moore, 1991, Ophthalmological screening for von Hippel-Lindau disease, Eye (Lond), 5, 723, 10.1038/eye.1991.133 · doi:10.1038/eye.1991.133
  21. Maher, 1990, Clinical features and natural history of von Hippel-Lindau disease, Q J Med, 77, 1151
  22. Dollfus, 2002, Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study, Invest Ophthalmol Vis Sci, 43, 3067
  23. Kreusel, 2006, Retinal angiomatosis in von Hippel-Lindau disease: a longitudinal ophthalmologic study, Ophthalmology, 113, 1418, 10.1016/j.ophtha.2006.02.059 · doi:10.1016/j.ophtha.2006.02.059
  24. Wong, 2008, Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau disease, Ophthalmology, 115, 181, 10.1016/j.ophtha.2007.03.009 · doi:10.1016/j.ophtha.2007.03.009
  25. Feletti, 2016, von Hippel-Lindau disease: an evaluation of natural history and functional disability, Neuro Oncol, 18, 1011, 10.1093/neuonc/nov313 · DOI
  26. Binderup, 2018, Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease, Br J Ophthalmol, 102, 942, 10.1136/bjophthalmol-2017-310884 · DOI
  27. Launbjerg, 2017, von Hippel-Lindau development in children and adolescents, Am J Med Genet A, 173, 2381, 10.1002/ajmg.a.38324 · doi:10.1002/ajmg.a.38324
  28. Melmon, 1964, Lindau’s disease. Review of the literature and study of a large kindred, Am J Med, 36, 595, 10.1016/0002-9343(64)90107-X · doi:10.1016/0002-9343(64)90107-x
  29. Chahoud, 2021, Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease, World J Urol, 39, 2409, 10.1007/s00345-020-03441-3 · DOI
  30. Huntoon, 2021, Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement, J Neurosurg, 136, 1511, 10.3171/2021.3.JNS204203 · doi:10.3171/2021.3.jns204203
  31. Mehta, 2021, Endolymphatic sac tumor screening and diagnosis in von Hippel-Lindau disease: a consensus statement, J Neurol Surg B Skull Base, 83, e225
  32. Laks, 2022, Management recommendations for pancreatic manifestations of von Hippel-Lindau disease, Cancer, 128, 435, 10.1002/cncr.33978 · DOI · Paper page
  33. Singh, 2001, Retinal capillary hemangioma: a comparison of sporadic cases and cases associated with von Hippel-Lindau disease, Ophthalmology, 108, 1907, 10.1016/S0161-6420(01)00758-8 · doi:10.1016/s0161-6420(01)00758-8
  34. Frantzen, 2012, Pregnancy-related hemangioblastoma progression and complications in von Hippel-Lindau disease, Neurology, 79, 793, 10.1212/WNL.0b013e3182661f3c · doi:10.1212/wnl.0b013e3182661f3c
  35. Ye, 2012, Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease, J Neurosurg, 117, 818
  36. Binderup, 2015, New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy, Neurology, 85, 1500, 10.1212/WNL.0000000000002064 · doi:10.1212/wnl.0000000000002064
  37. Othmane, 1999, Postpartum cerebellar herniation in von Hippel-Lindau syndrome, Am J Ophthalmol, 128, 387, 10.1016/S0002-9394(99)00199-3 · doi:10.1016/s0002-9394(99)00199-3
  38. Chen, 2018, Early detection of retinal hemangioblastomas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography, Retina, 38, 748, 10.1097/IAE.0000000000001601 · doi:10.1097/iae.0000000000001601
  39. Rasmussen, 2010, Uptake of genetic testing and long-term tumor surveillance in von Hippel-Lindau disease, BMC Med Genet, 11, 4, 10.1186/1471-2350-11-4 · doi:10.1186/1471-2350-11-4
  40. Lammens, 2011, Compliance with periodic surveillance for von-Hippel-Lindau disease, Genet Med, 13, 519, 10.1097/GIM.0b013e3182091a1d · DOI
  41. Wolters, 2022, Multidisciplinary integrated care pathway for von Hippel-Lindau disease, Cancer, 128, 2871, 10.1002/cncr.34265 · DOI · Paper page
  42. Taplin, 2015, Reviewing cancer care team effectiveness, J Oncol Pract, 11, 239, 10.1200/JOP.2014.003350 · DOI · Paper page
  43. Van Groenendael, 2015, High quality, patient centred and coordinated care for Alstrom syndrome: a model of care for an ultra-rare disease, Orphanet J Rare Dis, 10, 149, 10.1186/s13023-015-0366-y · doi:10.1186/s13023-015-0366-y
  44. von Kodolitsch, 2016, The role of the multidisciplinary health care team in the management of patients with Marfan syndrome, J Multidiscip Healthc, 9, 587, 10.2147/JMDH.S93680 · doi:10.2147/jmdh.s93680
  45. Auvin, 2019, A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report, Orphanet J Rare Dis, 14, 91, 10.1186/s13023-019-1072-y · DOI
  46. Gaudric, 2011, Vitreoretinal surgery for severe retinal capillary hemangiomas in von Hippel-Lindau disease, Ophthalmology, 118, 142, 10.1016/j.ophtha.2010.04.031 · DOI
  47. Krzystolik, 2016, Pars plana vitrectomy in advanced cases of von Hippel-Lindau eye disease, Retina, 36, 325, 10.1097/IAE.0000000000000707 · DOI
  48. Kreusel, 1998, Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma, Ophthalmology, 105, 1386, 10.1016/S0161-6420(98)98017-4 · doi:10.1016/s0161-6420(98)98017-4
  49. Raja, 2004, Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes, Ophthalmology, 111, 150, 10.1016/j.ophtha.2003.04.003 · doi:10.1016/j.ophtha.2003.04.003
  50. Singh, 2002, Treatment of retinal capillary hemangioma, Ophthalmology, 109, 1799, 10.1016/S0161-6420(02)01177-6 · DOI · Paper page
  51. Krivosic, 2017, Laser photocoagulation for peripheral retinal capillary hemangioblastoma in von Hippel-Lindau disease, Ophthalmol Retina, 1, 59, 10.1016/j.oret.2016.08.004 · doi:10.1016/j.oret.2016.08.004
  52. 2021, FDA OK’s HIF2α inhibitor belzutifan, Cancer Discov, 11, 2360, 10.1158/2159-8290.CD-NB2021-0377 · DOI
  53. Aronow, 2019, von Hippel-Lindau Disease: update on pathogenesis and systemic aspects, Retina, 39, 2243, 10.1097/IAE.0000000000002555 · DOI

Metadata

Authors
Daniels, A. B., Chang, E. Y., Chew, E. Y., Gombos, D. S., Gorin, M. B., Shields, C. L., & Wiley, H. E.
Venue
Ophthalmology
Publisher
Elsevier BV
Published
2024-05
Volume
131
Issue
5
Pages
622-633
ISSN
0161-6420
Cited by
26
References
3
Language
en
Licence
Funders
  • NEI (K08EY027464)
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease. https://app.cochat.ai/papers/10.1016/j.ophtha.2023.12.014
The paper
Daniels, A. B., Chang, E. Y., Chew, E. Y., Gombos, D. S., Gorin, M. B., Shields, C. L., & Wiley, H. E. (2024). Consensus Guidelines for Ocular Surveillance of von Hippel-Lindau Disease. Ophthalmology. https://doi.org/10.1016/j.ophtha.2023.12.014

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.